explore -WSS

explore

author：Wikipedia 2025-09-30 12:11:16 - browse：36

Gene therapy helped Conner Curran, right, walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. -- Biotech coverage from STAT — Gene therapy helped Conner Curran (at right) walk, but as the drug fades, his family is supporting scientific efforts to allow him and other boys get a second dose. Courtesy Jess & Chris Curran

In the beginning, Conner Curran ran up the stairs.

It was a miraculous moment for him and his parents, Jess and Chris Curran. Just months before, contractors were in their New York home to install a motorized lift, while Jess tearfully explained that it wasn’t for a grandparent but for their 7-year-old son, who suffered from Duchenne muscular dystrophy and could barely haul himself up the steps.

Then Conner was accepted as the first patient in Pfizer’s Duchenne gene therapy trial. Three weeks later, he could bound to the second floor. Soon, he could walk the two-plus miles to Goldberg’s, a local bagel shop. “I couldn’t do that before,” he told NPR in 2020.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Study: Black kids more likely to die after surgery than white kids

WSS

Undocumented workers face uncertainty as immigration law takes effect in Florida

Drug companies' payments and gifts affect physicians' prescribing

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Oral obesity drug from Viking Therapeutics hits key early target

Drug companies' payments and gifts affect physicians' prescribing

Republican states more likely to report Covid vaccine side effects

Wikipedia

explore

focus

Activists slam private health insurers over coverage restrictions

Harvard scientists, with Google, unveil the most detailed brain map ever

Jerome Adams on the need for new antivirals for Covid

Scientists uncover potential path to treating deadly childhood tumor

BioMarin wins approval for gene therapy to treat hemophilia A

What affirmative action's end means to a medical student

Tori Bowie and the unacceptable rates of Black maternal death

Vertex cell therapy lets patients with type 1 diabetes stop insulin

BioMarin wins approval for gene therapy to treat hemophilia A

Bird flu reported in person exposed to presumably infected cattle

Wikipedia

Dexcom's push to bring CGM to type 2 diabetes patients

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

A letter from the executive editor: The 2023 STATUS List

Gut bacteria may contribute to kidney autoimmunity, study finds

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Oral obesity drug from Viking Therapeutics hits key early target

knowledge

leisure time

focus

hotspot